Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer

MLA

Yu, Xufen, et al. “Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer.” Journal of Medicinal Chemistry, vol. 66, no. 23, Dec. 2023, pp. 16168–86. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.3c01521.

APA

Yu, X., Li, D., Kottur, J., Kim, H. S., Herring, L. E., Yu, Y., Xie, L., Hu, X., Chen, X., Cai, L., Liu, J., Aggarwal, A. K., Wang, G. G., & Jin, J. (2023). Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer. Journal of Medicinal Chemistry, 66(23), 16168–16186. https://doi.org/10.1021/acs.jmedchem.3c01521

Chicago

Yu, Xufen, Dongxu Li, Jithesh Kottur, Huen Suk Kim, Laura E. Herring, Yao Yu, Ling Xie, et al. 2023. “Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer.” Journal of Medicinal Chemistry 66 (23): 16168–86. doi:10.1021/acs.jmedchem.3c01521.